H.C. Wainwright Assumes Larimar Therapeutics (LRMR) at Buy

July 2, 2026 6:05 AM EDT Send to a Friend
(Updated - July 2, 2026 6:46 AM EDT)

H.C. Wainwright analyst Raghuram Selvaraju assumes coverage on Larimar Therapeutics (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login